Insider Transactions in Q1 2025 at Evoke Pharma Inc (EVOK)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2025
|
Matthew J D'Onofrio Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,849
+43.71%
|
$20,547
$3.65 P/Share
|
|
Jan 28
2025
|
Nantahala Capital Management, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
41
-0.03%
|
$164
$4.39 P/Share
|